Results 291 to 300 of about 365,877 (337)
Melittin Acts as a Radiosensitizer for Non-Small Cell Lung Cancer by Inhibiting the DNA Damage Repair System and Inducing Apoptosis. [PDF]
Seo E, Seo H, Kim KO, Lee KC.
europepmc +1 more source
Abstract Background and Purpose Immune checkpoint inhibitors (ICI) have revolutionized cancer therapy, offering improvements in survival across various malignancies. However, their toxicities pose a major challenge for cardio‐oncology units. Despite their growing importance, data on effectiveness of such specialized units in mitigating ICI‐associated ...
Elias Haj‐Yehia +6 more
wiley +1 more source
This study found immune markers that may predict how well patients with advanced lung cancer respond to atezolizumab. Higher levels of certain T cells were linked to better survival. Specific patterns suggested a worse prognosis for some patients. ABSTRACT We investigated immunologic biomarkers that predict outcomes of patients with previously treated ...
Atsuto Mouri +24 more
wiley +1 more source
Clinicopathological characteristics and prognosis of brain metastasis in non-small cell lung cancer: A retrospective study. [PDF]
Fu X, Liu Q, Jia J, Wang M.
europepmc +1 more source
Peritoneal carcinomatosis in metastatic Non-Small Cell Lung Cancer: review of the literature. [PDF]
Meriggi F +5 more
europepmc +1 more source
Erosive pustular dermatosis-like scalp reaction following cranial radiotherapy in a patient with EGFR-mutant NSCLC treated with amivantamab. [PDF]
Nikolaou V +5 more
europepmc +1 more source
LINE-1 Transcript Heterogeneity in Non-Small Cell Lung Cancers Is Driven by Host Genomic Context and Conserved Functional Hotspots. [PDF]
Wang Y, Ramos KS.
europepmc +1 more source
KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC
Tubita A +12 more
openalex +1 more source

